342 related articles for article (PubMed ID: 33467676)
1. A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT
Raval NR; Johansen A; Donovan LL; Ros NF; Ozenne B; Hansen HD; Knudsen GM
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467676
[TBL] [Abstract][Full Text] [Related]
2. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
[TBL] [Abstract][Full Text] [Related]
3. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.
Madsen MK; Fisher PM; Stenbæk DS; Kristiansen S; Burmester D; Lehel S; Páleníček T; Kuchař M; Svarer C; Ozenne B; Knudsen GM
Eur Neuropsychopharmacol; 2020 Apr; 33():71-80. PubMed ID: 32146028
[TBL] [Abstract][Full Text] [Related]
4. Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.
Stenbæk DS; Madsen MK; Ozenne B; Kristiansen S; Burmester D; Erritzoe D; Knudsen GM; Fisher PM
J Psychopharmacol; 2021 Apr; 35(4):459-468. PubMed ID: 33501857
[TBL] [Abstract][Full Text] [Related]
5. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.
Hesselgrave N; Troppoli TA; Wulff AB; Cole AB; Thompson SM
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33850049
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT
Sekssaoui M; Bockaert J; Marin P; Bécamel C
Neuropsychopharmacology; 2024 Mar; 49(4):747-756. PubMed ID: 38212441
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.
Muguruza C; Miranda-Azpiazu P; Díez-Alarcia R; Morentin B; González-Maeso J; Callado LF; Meana JJ
Neuropharmacology; 2014 Nov; 86():311-8. PubMed ID: 25150943
[TBL] [Abstract][Full Text] [Related]
8. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
Lian J; Huang XF; Pai N; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
[TBL] [Abstract][Full Text] [Related]
9. Effects of a single dose of psilocybin on behaviour, brain 5-HT
Donovan LL; Johansen JV; Ros NF; Jaberi E; Linnet K; Johansen SS; Ozenne B; Issazadeh-Navikas S; Hansen HD; Knudsen GM
Eur Neuropsychopharmacol; 2021 Jan; 42():1-11. PubMed ID: 33288378
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
[TBL] [Abstract][Full Text] [Related]
11. Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.
Odland AU; Kristensen JL; Andreasen JT
Behav Brain Res; 2021 Mar; 401():113093. PubMed ID: 33359368
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 5-HT
Gener T; Tauste Campo A; Alemany-González M; Nebot P; Delgado-Sallent C; Chanovas J; Puig MV
Neuropharmacology; 2019 Nov; 158():107743. PubMed ID: 31430459
[TBL] [Abstract][Full Text] [Related]
13. The selective 5-HT
Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
[TBL] [Abstract][Full Text] [Related]
14. Serotonin 2A Receptor (5-HT
Duan W; Cao D; Wang S; Cheng J
Chem Rev; 2024 Jan; 124(1):124-163. PubMed ID: 38033123
[TBL] [Abstract][Full Text] [Related]
15. Structure-based discovery of nonhallucinogenic psychedelic analogs.
Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
[TBL] [Abstract][Full Text] [Related]
16. Effects of the 5-HT
Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
[TBL] [Abstract][Full Text] [Related]
17. Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.
Lee HJ; Tsang VW; Chai BS; Lin MC; Howard A; Uy C; Elefante JO
J Psychoactive Drugs; 2024; 56(3):301-315. PubMed ID: 37385217
[TBL] [Abstract][Full Text] [Related]
18. 5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system.
Quesseveur G; Repérant C; David DJ; Gardier AM; Sanchez C; Guiard BP
Exp Brain Res; 2013 Apr; 226(2):285-95. PubMed ID: 23411676
[TBL] [Abstract][Full Text] [Related]
19. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
20. A single dose of cocaine raises SV2A density in hippocampus of adolescent rats.
Rossi R; Bærentzen SL; Thomsen MB; Real CC; Wegener G; Grassi-Oliveira R; Gjedde A; Landau AM
Acta Neuropsychiatr; 2024 Apr; 36(2):109-117. PubMed ID: 36847240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
